Aimei Health Technology (NASDAQ:AFJK) Shares Down 2.2% – Should You Sell?

Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) fell 2.2% on Wednesday . The company traded as low as $45.60 and last traded at $45.1150. 4,163 shares traded hands during trading, a decline of 84% from the average session volume of 26,099 shares. The stock had previously closed at $46.12.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on AFJK. Weiss Ratings reissued a “sell (d+)” rating on shares of Aimei Health Technology in a research report on Friday, March 27th. Wall Street Zen raised shares of Aimei Health Technology to a “sell” rating in a research report on Saturday, January 17th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, Aimei Health Technology has an average rating of “Sell”.

Aimei Health Technology Trading Up 5.7%

The stock has a market capitalization of $282.62 million, a price-to-earnings ratio of 219.92 and a beta of 0.45. The stock’s 50 day moving average is $34.48 and its two-hundred day moving average is $34.35.

Hedge Funds Weigh In On Aimei Health Technology

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Clear Street Group Inc. boosted its stake in Aimei Health Technology by 36.5% in the 4th quarter. Clear Street Group Inc. now owns 83,337 shares of the company’s stock worth $5,334,000 after purchasing an additional 22,294 shares during the period. Jane Street Group LLC acquired a new position in Aimei Health Technology in the 4th quarter worth $302,000. Geode Capital Management LLC acquired a new stake in Aimei Health Technology in the 4th quarter valued at $413,000. Dakota Wealth Management acquired a new stake in Aimei Health Technology in the 4th quarter valued at $406,000. Finally, Quarry LP increased its stake in Aimei Health Technology by 6.4% in the 3rd quarter. Quarry LP now owns 167,081 shares of the company’s stock valued at $1,891,000 after buying an additional 10,000 shares during the last quarter. 45.58% of the stock is owned by institutional investors and hedge funds.

Aimei Health Technology Company Profile

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co, Ltd was incorporated in 2023 and is based in New York, New York.